Hisako Okuhira
Wakayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Finger sweating levels evaluated by video capillaroscopy system are increased in patients with systemic sclerosis compared to pre-clinical stage patients.
Journal: Drug discoveries & therapeutics
Published: January 04, 2021
Difference in distribution of malignant melanoma and melanocytic nevus in the palm and finger.
Journal: Bioscience trends
Published: September 19, 2019
Anaphylaxis to ginger induced by herbal medicine.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: April 30, 2019
Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma.
Journal: Frontiers in medicine
Published: February 17, 2019
Clinical and histological evaluation of a single high energy microwave treatment for primary axillary hyperhidrosis in Asians: A prospective, randomized, controlled, split-area comparative trial.
Journal: Lasers in surgery and medicine
Published: January 26, 2019
Prognostic factors of daily blood examination for advanced melanoma patients treated with nivolumab.
Prognostic factors of daily blood examination for advanced melanoma patients treated with nivolumab.
Journal: Bioscience trends
Published: August 31, 2018
Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma.
Journal: Frontiers in oncology
Published: June 30, 2018
Baseline neutrophil to lymphocyte ratio combined with serum lactate dehydrogenase level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population.
Journal: The British journal of dermatology
Published: February 07, 2018
Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.
Journal: Oncotarget
Published: September 01, 2017
Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients.
Journal: Journal of dermatological science
Published: August 09, 2017
Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab.
Journal: Journal of dermatological science
Published: April 07, 2017
Last Updated: 09/26/2026